PTP1B inhibitors (Biovitrum)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePTP1B inhibitors (Biovitrum)
Drug Alias NamePTP1B inhibitors (Biovitrum)protein tyrosine phosphatase 1B inhibitors (Biovitrum)CCK-8 analogs (Biovitrum)BVT-31BVT-520 +[7] 
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionProtein-tyrosine phosphatase 1B inhibitorsInsulin sensitizers
TargetsProtein-tyrosine phosphatase 1B
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSwedish Orphan Biovitrum Ab (Publ)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSwedish Orphan Biovitrum Ab (Publ)
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A